01 1Sun Pharmaceutical Industries Limited
01 1METFORMIN HYDROCHLORIDE USP (LDMA PROCESS)
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2025-03-03
Pay. Date : 2025-01-31
DMF Number : 41221
Submission : 2025-01-31
Status : Active
Type : II
20
Sun Pharmaceutical Industries Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is METFORMIN HYDROCHLORIDE USP (LDMA PROCESS), with a corresponding US DMF Number 41221.
Remarkably, this DMF maintains an Active status since its submission on January 31, 2025, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 03, 2025, and payment made on January 31, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II
